Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Mithramycin oxime derivatives having increased selectivity and anti-cancer activity

US Patent 11466045 · Granted Oct 11, 2022

Estimated economic value: $15,598,000

Assignee

Inventors

View full patent text on Google Patents →